Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Post-Surgical Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 24 |
| Updated: | 3/7/2019 |
| Start Date: | May 1, 2019 |
| End Date: | March 1, 2023 |
| Contact: | Monica Weber, BSN |
| Email: | monij@med.umich.edu |
| Phone: | (734) 936-0734 |
Legitimate prescription opioid use during adolescence has been associated with later
prescription opioid misuse and substance use disorder symptoms during adulthood. Thus,
primary prevention interventions for older adolescents and young adults (18-24 yrs) at the
time of prescribing are imperative.
The goal of our research is to improve opioid analgesic safety and efficacy by optimizing
opioid risk recognition and informed decision-making among 18-24 year olds who are prescribed
these agents for home use. Young adults and older adolescents who manage their own
prescription pain medicines need to recognize opioid-related risks and make decisions that
will both reduce these risks yet ensure effective pain relief. The proposed research will
evaluate new strategies to help subjects learn about opioid risks and make safe and effective
analgesic decisions. 355 subjects who are undergoing an elective surgical procedure will be
recruited. Subjects will be randomized to receive the new educational routine information.
Subjects' knowledge and perceptions will be evaluated at baseline and at critical times after
surgery.
prescription opioid misuse and substance use disorder symptoms during adulthood. Thus,
primary prevention interventions for older adolescents and young adults (18-24 yrs) at the
time of prescribing are imperative.
The goal of our research is to improve opioid analgesic safety and efficacy by optimizing
opioid risk recognition and informed decision-making among 18-24 year olds who are prescribed
these agents for home use. Young adults and older adolescents who manage their own
prescription pain medicines need to recognize opioid-related risks and make decisions that
will both reduce these risks yet ensure effective pain relief. The proposed research will
evaluate new strategies to help subjects learn about opioid risks and make safe and effective
analgesic decisions. 355 subjects who are undergoing an elective surgical procedure will be
recruited. Subjects will be randomized to receive the new educational routine information.
Subjects' knowledge and perceptions will be evaluated at baseline and at critical times after
surgery.
The goal of this research is to improve opioid analgesic safety and efficacy by optimizing
opioid risk recognition, informed decision-making including misuse among 18-24 year olds who
are prescribed these agents for home use.
This is a randomized, controlled study design. The investigators will enroll emerging adults
(aged 18-24 yrs) who are scheduled to undergo a surgical procedure and will be prescribed an
opioid as part of their routine postoperative care. Comprehensive informed consent will be
obtained.
No medical treatments will be altered for the purposes of this educational study. All
participants will complete baseline surveys to assess their pain medicine familiarity, their
opioid risk knowledge and perceptions, and their analgesic self-efficacy and their pain
relief/ risk avoidance preferences. Participants will also be presented (via the survey
platform) with several hypothetical (mock) scenarios and will be asked to make hypothetical
decisions about how they would treat pain for each.
The Intervention group will receive tailored feedback and guidance after each scenario (i.e.,
the Scenario Tailored Opioid Messages) and the Control group will receive only routine
analgesic risk and benefit information. Participants will complete the post-scenario/feedback
surveys to re-assess opioid risk perceptions and self-efficacy and will complete brief health
literacy surveys.
On days 14 and at one month, participants will be resurveyed (via emailed qualtrics survey
link or paper -whichever is preferred) about their opioid risk knowledge, perceptions,
scenario decision making, analgesic self-efficacy and pain relief/risk avoidance preferences.
All surveys and datasheets will contain unique identifiers only. Identifiers will be
maintained separately from survey data (linked only by unique identifier) to maintain
privacy. Participants will receive up to $50 for participation.
opioid risk recognition, informed decision-making including misuse among 18-24 year olds who
are prescribed these agents for home use.
This is a randomized, controlled study design. The investigators will enroll emerging adults
(aged 18-24 yrs) who are scheduled to undergo a surgical procedure and will be prescribed an
opioid as part of their routine postoperative care. Comprehensive informed consent will be
obtained.
No medical treatments will be altered for the purposes of this educational study. All
participants will complete baseline surveys to assess their pain medicine familiarity, their
opioid risk knowledge and perceptions, and their analgesic self-efficacy and their pain
relief/ risk avoidance preferences. Participants will also be presented (via the survey
platform) with several hypothetical (mock) scenarios and will be asked to make hypothetical
decisions about how they would treat pain for each.
The Intervention group will receive tailored feedback and guidance after each scenario (i.e.,
the Scenario Tailored Opioid Messages) and the Control group will receive only routine
analgesic risk and benefit information. Participants will complete the post-scenario/feedback
surveys to re-assess opioid risk perceptions and self-efficacy and will complete brief health
literacy surveys.
On days 14 and at one month, participants will be resurveyed (via emailed qualtrics survey
link or paper -whichever is preferred) about their opioid risk knowledge, perceptions,
scenario decision making, analgesic self-efficacy and pain relief/risk avoidance preferences.
All surveys and datasheets will contain unique identifiers only. Identifiers will be
maintained separately from survey data (linked only by unique identifier) to maintain
privacy. Participants will receive up to $50 for participation.
Inclusion Criteria:
- Undergoing an elective surgical procedure for which it is expected they will receive a
prescription pain medicine for management of pain during recovery at home.
Exclusion Criteria:
- Undergoing non-elective procedure
- Cognitive impairment precluding self-reporting of pain
- Hematologic/oncologic condition
- Liver of kidney conditions precluding usual analgesic prescription patters (opioid
plus a non-opioid)
- Use of opioids for prolonged pain pre-operatively (<2 weeks)
We found this trial at
1
site
Click here to add this to my saved trials
